GUARNERI, VALENTINA

GUARNERI, VALENTINA  

Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG  

Risultati 1 - 20 di 237 (tempo di esecuzione: 0.154 secondi).
Titolo Data di pubblicazione Autore(i) Rivista Serie Titolo libro
Epirubicin/taxane combinations in breast cancer: experience from several Italian trials 2001 CONTE, PIERFRANCOGUARNERI, VALENTINA + ONCOLOGY-NEW YORK - -
New combinations with epirubicin in advanced breast cancer. 2001 CONTE, PIERFRANCOGUARNERI, VALENTINA + ONCOLOGY-NEW YORK - -
High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC). 2001 GUARNERI, VALENTINACONTE, PIERFRANCO + ANNALS OF ONCOLOGY - -
Rischio neoplastico post-trapianto 2001 GUARNERI, VALENTINA + - - I trapianti di pancreas
Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer. 2002 GUARNERI, VALENTINACONTE, PIERFRANCO + CLINICAL BREAST CANCER - -
High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study. 2003 GUARNERI, VALENTINACONTE, PIERFRANCO + BONE MARROW TRANSPLANTATION - -
HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support 2004 GUARNERI, VALENTINACONTE, PIERFRANCO + BONE MARROW TRANSPLANTATION - -
Le Cellule Staminali Mesenchimali: Aspetti Biologici ed Approcci Terapeutici 2004 GUARNERI, VALENTINACONTE, PIERFRANCO + TRENDS IN MEDICINE - -
Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma - Results from the Gruppo Oncologico Nord Ovest randomized trial 2004 CONTE, PIERFRANCOGUARNERI, VALENTINA + CANCER - -
The curability of breast cancer and the treatment of advanced disease 2004 GUARNERI, VALENTINACONTE, PIERFRANCO EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING - -
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy 2004 GUARNERI, VALENTINACONTE, PIERFRANCO + BRITISH JOURNAL OF CANCER - -
Safety of intravenous and oral bisphosphonates and compliance with dosing regimens 2004 CONTE, PIERFRANCOGUARNERI, VALENTINA THE ONCOLOGIST - -
Renal safety of zoledronic acid in patients with bone metastases from breast cancer (BC) or other tumors treated with IV BisphosphonateS (BPS) for up to ten years 2004 GUARNERI, VALENTINACONTE, PIERFRANCO + ANNALS OF ONCOLOGY - -
Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma 2005 GUARNERI, VALENTINACONTE, PIERFRANCO + BRITISH JOURNAL OF CANCER - -
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study 2005 CONTE, PIERFRANCOGUARNERI, VALENTINA + BRITISH JOURNAL OF CANCER - -
High dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transpalntation (EBMT) 2005 GUARNERI, VALENTINACONTE, PIERFRANCO + BONE MARROW TRANSPLANTATION - -
The Issue of Renal Safety of Zoledronic Acid from a Nephrologist's Point of View 2005 CONTE, PIERFRANCOGUARNERI, VALENTINA + THE ONCOLOGIST - -
Renal safety and efficacy of intravenous bisphosphonates in patients with skeletal metastases treated for up to ten years 2005 GUARNERI, VALENTINACONTE, PIERFRANCO + THE ONCOLOGIST - -
In response to Jackson letter to the editor regarding safety of intravenous and oral bisphosphonates and compliance with dosing regimens 2005 CONTE, PIERFRANCOGUARNERI, VALENTINA THE ONCOLOGIST - -
Predictive value of biological parameters for primary chemotherapy in operable breast cancer 2005 GUARNERI, VALENTINACONTE, PIERFRANCO + CLINICAL BREAST CANCER - -